fluorodeoxyglucose f18 has been researched along with Movement Disorders in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (12.50) | 18.7374 |
1990's | 2 (8.33) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 11 (45.83) | 24.3611 |
2020's | 4 (16.67) | 2.80 |
Authors | Studies |
---|---|
de Jong, BM; Dierckx, RAJO; Klamer, MR; Lammertsma, AA; Marapin, RS; Tijssen, MAJ; Timmers, ER | 1 |
Delva, A; Van Laere, K; Vandenberghe, W | 1 |
Apostolova, I; Barthel, H; Berding, G; Brendel, M; Buchert, R; Buhmann, C; Dierks, A; Eidelberg, D; Höglinger, G; Huppertz, HJ; Katzdobler, S; Klietz, M; Levin, J; Mahmoudi, N; Rinscheid, A; Rogozinski, S; Rumpf, JJ; Sabri, O; Schneider, C; Spetsieris, PG; Stöcklein, S; Wattjes, MP; Wegner, F | 1 |
De Vincentis, G; Frantellizzi, V; Madeddu, G; Nuvoli, S; Palumbo, B; Spanu, A; Stazza, ML; Tanda, G | 1 |
Bastianello, M; Biafore, F; Depetris, TS; Peralta, C | 1 |
Catenoix, H; Guénot, M; Isnard, J; Kahane, P; Montavont, A; Ostrowsky-Coste, K; Rheims, S; Ryvlin, P | 1 |
Chung, E; Kim, D; Kim, HI; Kim, HS; Kim, JM; Kim, RG; Lee, MC; Neto, PR | 1 |
Chung, M; Huh, R; Jang, SJ; Kim, HS; Kim, JS; Kim, WC; Kim, YJ; Ma, HI; Park, YS | 1 |
Amtage, F; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C | 1 |
Boecker, H; Drzezga, AE; Götz, J; Granert, O; Häussermann, P; Kurz, A; Perneczky, R; van Eimeren, T | 1 |
Drzezga, A | 1 |
Drzezga, A; Mallik, AK; Minoshima, S | 1 |
Kim, HS; Lee, MS; Lim, HS; Lyoo, CH; Nam, CM; Rinne, JO; Ryu, YH | 1 |
Cole, MH; Coyne, T; Kerr, G; Silburn, P; Wilcox, RA; Wong, D | 1 |
Fung, VS; Kotschet, K; Krause, M; Mahant, N; Morris, JG; Vagg, D; Wong, CH | 1 |
Besret, L; Bottlaender, M; Condé, F; Dauguet, J; Dollé, F; Drouot, X; Hantraye, P; Jarraya, B; Kéravel, Y; Kishima, H; Lefaucheur, JP; Oshino, S; Palfi, S; Peschanski, M; Remy, P | 1 |
Al-Essa, M; Al-Shamsan, L; Bakheet, S; Ozand, PT; Patay, Z; Powe, J | 1 |
Bynum, L; DeCesare, S; Elder, EM; Gebel, J; Goldstein, S; Jannetta, P; Kondziolka, D; McGrogan, M; Meltzer, C; Reitman, MA; Thulborn, KR; Wechsler, L | 1 |
DeCesare, S; Elder, EM; Gebel, J; Goldstein, S; Jacobs, A; Kondziolka, D; Meltzer, CC; Thulborn, KR; Villemagne, VL; Wechsler, L | 1 |
Borbély, K | 1 |
Agid, Y; Blin, J; Dubois, B; Feve, JR; Pillon, B; Vidailhet, MJ | 1 |
Di Chiro, G; Dubinsky, RM; Hallett, M; Levey, R | 1 |
Baker, M; Di Chiro, G; Dubinsky, RM; Greenberg, M; Hallett, M | 1 |
Wagner, HN | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Movement Disorders
Article | Year |
---|---|
[
Topics: Ataxia; Chorea; Dystonia; Fluorodeoxyglucose F18; Glucose; Humans; Hyperkinesis; Movement Disorders; Myoclonus; Tics; Tremor | 2023 |
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
Topics: Apathy; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2019 |
Molecular Imaging and Precision Medicine in Dementia and Movement Disorders.
Topics: Biomarkers, Tumor; Dementia; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Molecular Targeted Therapy; Movement Disorders; Positron-Emission Tomography; Precision Medicine; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2017 |
[Functional neuroimaging in movement disorders].
Topics: Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Movement Disorders; Nerve Tissue Proteins; Parkinson Disease; Radiopharmaceuticals; Receptors, Dopamine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
2 trial(s) available for fluorodeoxyglucose f18 and Movement Disorders
Article | Year |
---|---|
Transplantation of cultured human neuronal cells for patients with stroke.
Topics: Adult; Aged; Basal Ganglia; Cells, Cultured; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Neurons; Severity of Illness Index; Single-Blind Method; Stem Cell Transplantation; Stem Cells; Stroke; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke.
Topics: Aged; Basal Ganglia; Cells, Cultured; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Neurologic Examination; Neurons; Radiopharmaceuticals; Severity of Illness Index; Stereotaxic Techniques; Stroke; Temporal Lobe; Time Factors; Tomography, Emission-Computed | 2001 |
18 other study(ies) available for fluorodeoxyglucose f18 and Movement Disorders
Article | Year |
---|---|
Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.
Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Membrane Glycoproteins; Movement Disorders; Nerve Tissue Proteins; Positron-Emission Tomography | 2023 |
Automatic covariance pattern analysis outperforms visual reading of
Topics: Fluorodeoxyglucose F18; Humans; Movement Disorders; Positron-Emission Tomography; Retrospective Studies; Supranuclear Palsy, Progressive | 2023 |
123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Movement Disorders; Neurodegenerative Diseases; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2021 |
Hypermotor seizures in lateral and mesial parietal epilepsy.
Topics: Adult; Child, Preschool; Electroencephalography; Epilepsies, Partial; Extremities; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Positron-Emission Tomography; Seizures; Young Adult | 2013 |
A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study.
Topics: Animals; Behavior, Animal; Brain Infarction; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Internal Capsule; Intracranial Thrombosis; Male; Motor Activity; Movement Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Recovery of Function | 2014 |
Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
Topics: Aged; Aged, 80 and over; Brain; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Movement Disorders; Multimodal Imaging; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tropanes | 2015 |
18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lewy Body Disease; Male; Middle Aged; Movement Disorders; Parkinsonian Disorders; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Survival Analysis | 2015 |
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Movement Disorders; Neurodegenerative Diseases; Parkinson Disease; Parkinson Disease, Postencephalitic; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
2016 SNMMI Highlights Lecture: Neurosciences.
Topics: Fluorodeoxyglucose F18; Humans; Mental Disorders; Movement Disorders; Neurosciences; Nuclear Medicine; Positron-Emission Tomography; Protein Aggregation, Pathological; Societies, Medical | 2016 |
The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease.
Topics: Aged; Aged, 80 and over; Aging; Case-Control Studies; Cerebral Cortex; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Movement Disorders; Parkinson Disease; Positron-Emission Tomography | 2011 |
Pedunculopontine nucleus deep brain stimulation produces sustained improvement in primary progressive freezing of gait.
Topics: Aged; Deep Brain Stimulation; Fluorodeoxyglucose F18; Gait; Humans; Male; Movement Disorders; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2011 |
Dysexecutive behaviour following deep brain lesions--a different type of disconnection syndrome?
Topics: Adolescent; Adult; Aged; Aphasia; Behavior; Brain Damage, Chronic; Executive Function; Female; Fluorodeoxyglucose F18; Frontal Lobe; Globus Pallidus; Hallucinations; Humans; Immersion; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Nerve Net; Positron-Emission Tomography; Respiratory Tract Infections; Speech Disorders; Subarachnoid Hemorrhage | 2012 |
Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation.
Topics: Animals; Chronic Disease; Disease Models, Animal; Electric Stimulation; Electrophysiology; Fluorodeoxyglucose F18; Motor Cortex; Movement Disorders; MPTP Poisoning; Papio; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Recovery of Function | 2004 |
18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
Topics: Brain; Brain Diseases; Child; Child, Preschool; Fluorodeoxyglucose F18; Glutarates; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Nervous System Diseases; Optic Atrophy; Paraplegia; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
Topics: Aged; Apraxias; Blood Glucose; Brain Mapping; Cerebral Cortex; Corpus Striatum; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Nerve Degeneration; Substantia Nigra; Thalamic Nuclei; Tomography, Emission-Computed | 1992 |
Regional brain glucose metabolism in neuroacanthocytosis.
Topics: Acanthocytes; Adult; Brain; Deoxyglucose; Erythrocytes, Abnormal; Fluorodeoxyglucose F18; Glucose; Hematologic Diseases; Humans; Male; Movement Disorders; Seizures; Syndrome; Tissue Distribution; Tomography, Emission-Computed | 1989 |
Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose.
Topics: Adolescent; Adult; Aged; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Putamen; Tomography, Emission-Computed | 1989 |
Rett syndrome: positron emission tomography (PET) studies.
Topics: Adult; Age Factors; Aged; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Intellectual Disability; Male; Middle Aged; Movement Disorders; Receptors, Dopamine; Spiperone; Syndrome; Time Factors; Tomography, Emission-Computed | 1986 |